Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction
Topic:
Hypertension, Pulmonary Hypertension
Event:
ESC Congress 2020
Congress Presentation
6 more presentations in this session
Access the full session
About the event
